弥漫性增殖性狼疮性肾炎治疗的中断 - Suppr

Suppr

超能文献

Discontinuation of therapy in diffuse proliferative lupus nephritis.

作者信息

Ponticelli C, Moroni G, Banfi G

机构信息

Ospedale Maggiore, Milano, Italy.

出版信息

Am J Med. 1988 Aug;85(2):275.

PMID:3400709

Abstract

摘要

相似文献

Discontinuation of therapy in diffuse proliferative lupus nephritis.弥漫性增殖性狼疮性肾炎治疗的中断

Am J Med. 1988 Aug;85(2):275.

Approach to lupus nephritis based upon randomized trials.基于随机试验的狼疮性肾炎治疗方法。

Contrib Nephrol. 1992;99:46-54. doi: 10.1159/000421688.

A randomized pilot trial comparing cyclosporine and azathioprine for maintenance therapy in diffuse lupus nephritis over four years.一项为期四年的比较环孢素和硫唑嘌呤用于弥漫性狼疮性肾炎维持治疗的随机试点试验。

Clin J Am Soc Nephrol. 2006 Sep;1(5):925-32. doi: 10.2215/CJN.02271205. Epub 2006 Jun 28.

Azathioprine/methylprednisolone versus cyclophosphamide in proliferative lupus nephritis. A randomized controlled trial.硫唑嘌呤/甲泼尼龙与环磷酰胺治疗增殖性狼疮性肾炎的疗效比较：一项随机对照试验

Kidney Int. 2006 Aug;70(4):732-42. doi: 10.1038/sj.ki.5001630. Epub 2006 Jul 5.

[Cyclophosphamide-induced lupus flare in diffuse proliferative lupus nephropathy].[环磷酰胺诱发的弥漫性增殖性狼疮性肾炎狼疮发作]

Nefrologia. 2011;31(2):231-3. doi: 10.3265/Nefrologia.pre2010.Nov.10674.

Treatment of proliferative lupus nephritis with methylprednisolone pulse therapy and oral azathioprine.

Neth J Med. 1995 Jan;46(1):4-14. doi: 10.1016/0300-2977(94)00085-n.

Long-term follow-up of a randomised controlled trial of azathioprine/methylprednisolone versus cyclophosphamide in patients with proliferative lupus nephritis.增殖性狼疮肾炎患者硫唑嘌呤/甲泼尼龙与环磷酰胺随机对照试验的长期随访。

Ann Rheum Dis. 2012 Jun;71(6):966-73. doi: 10.1136/annrheumdis-2011-200384. Epub 2011 Nov 29.

Treatment of proliferative lupus nephritis: a changing landscape.增殖性狼疮性肾炎的治疗：不断变化的格局。

Kidney Int. 2006 Aug;70(4):616-8. doi: 10.1038/sj.ki.5001722.

EULAR randomised controlled trial of pulse cyclophosphamide and methylprednisolone versus continuous cyclophosphamide and prednisolone followed by azathioprine and prednisolone in lupus nephritis.欧洲抗风湿病联盟关于狼疮性肾炎的随机对照试验：脉冲环磷酰胺和甲泼尼龙对比持续环磷酰胺和泼尼松龙后接硫唑嘌呤和泼尼松龙

Ann Rheum Dis. 2004 May;63(5):525-9. doi: 10.1136/ard.2002.003574.

Treatment of diffuse proliferative lupus nephritis.

Contrib Nephrol. 1992;99:55-9. doi: 10.1159/000421689.

引用本文的文献

Immunosuppressives discontinuation after renal response in lupus nephritis: predictors of flares, time to withdrawal and long-term outcomes.狼疮性肾炎肾脏缓解后停用免疫抑制剂：复发的预测因素、停药时间及长期结局

Rheumatology (Oxford). 2025 Apr 1;64(4):1894-1903. doi: 10.1093/rheumatology/keae381.

2022 Systemic lupus erythematosus remission in clinical practice. Message for Polish rheumatologists.2022年临床实践中的系统性红斑狼疮缓解。致波兰风湿病学家的信息。

Reumatologia. 2022;60(2):125-132. doi: 10.5114/reum.2022.115667. Epub 2022 May 18.

Low-dose belimumab for patients with systemic lupus erythematosus at low disease activity: protocol for a multicentre, randomised, double-blind, placebo-controlled clinical trial.低疾病活动度系统性红斑狼疮患者的低剂量贝利尤单抗治疗：一项多中心、随机、双盲、安慰剂对照临床试验方案。

Lupus Sci Med. 2022 Feb;9(1). doi: 10.1136/lupus-2021-000638.

Glucocorticoid withdrawal in systemic lupus erythematosus: are remission and low disease activity reliable starting points for stopping treatment? A real-life experience.系统性红斑狼疮中糖皮质激素的撤药：缓解和低疾病活动度是否是停药的可靠起点？真实经验。

RMD Open. 2019 Jun 11;5(2):e000916. doi: 10.1136/rmdopen-2019-000916. eCollection 2019.

Steroid-free remission in lupus: myth or reality; an observational study from a tertiary referral centre.狼疮无激素缓解：是神话还是现实；来自三级转诊中心的观察性研究。

Clin Rheumatol. 2019 Apr;38(4):1089-1097. doi: 10.1007/s10067-018-4377-7. Epub 2018 Dec 6.

Remission and withdrawal of therapy in lupus nephritis.狼疮性肾炎的缓解与治疗撤停

J Nephrol. 2016 Aug;29(4):559-65. doi: 10.1007/s40620-016-0313-6. Epub 2016 May 4.

Lupus nephritis in childhood and adolescence.儿童及青少年狼疮性肾炎

Pediatr Nephrol. 1994 Apr;8(2):230-49. doi: 10.1007/BF00865490.

Current treatment recommendations for lupus nephritis.狼疮性肾炎的当前治疗建议。

Drugs. 1990 Jul;40(1):19-30. doi: 10.2165/00003495-199040010-00003.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验